Report

1st Circ. Revives Amgen Migraine Drug Risk Label Suit

Report from the legal press

Headline as published by Law360 Life Sciences on Oct 13, 2026; collected by the wire Oct 13, 2026, 5:45 PM ET.

Read at Law360 Life Sciences

Coverage

  1. Law360 Life Sciences Legal press

    1st Circ. Revives Amgen Migraine Drug Risk Label Suit

Named in this story

Topics

  • Drugs and medical devicesFrom the publisher’s section: no phrase in the text matched, so the tag comes from where Law360 Life Sciences filed it.

Explore the named firms, organizations and MDL dockets above. Sources and method